Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects

by Dr. Trupti Shirole on  February 5, 2015 at 12:56 AM Medico Legal News
RSS Email Print This Page Comment bookmark
Font : A-A+

Japanese health authorities will soon make a decision on a possible penalty against the local unit of Swiss pharmaceutical giant Novartis for failing to report drug side effects in more than 3,000 cases that may have been caused by about two dozen company drugs.
 Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects
Novartis Japan Will Face Penalty Over Failing to Report Drug Side Effects

The regulators would slap a 15-day suspension order on the firm, meaning the company could not sell most of its drugs during the two-week period. A spokesman said, "We haven't decided anything yet, but it should be announced soon."

The Swiss firm's Japanese unit declined to comment on Wednesday. However, the health ministry said that a decision was imminent.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Nervous Tic Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive